Mastering HR Summit 2011

North West Business Group30 - 31 March 2011, Frankfurt am Main, Germany.
Mastering Human Resourcing 2011 has been specifically designed to address the particular challenges current - and future - leaders face. This interactive 2 day course will be a gathering for HR executives from companies across the industries to exchange ideas, develop new partnerships and discuss the latest tools, technologies and strategies being employed in the profession to enhance departmental efficiencies and drive corporate growth.

The goal of Mastering HR 2011 is to offer valuable knowledge transfer and networking as well as to highlight future trends. We are aiming to attract all HR managers and specialists, HR service agencies, high-level personnel and line managers as well as the next generation in the profession from all over Europe.

The event will focus on the most current topics in the HR industry such as:

  • Global Diversity Management
  • Innovative HR Trends
  • ROI of Human Capital
  • Managing Different generations
  • HR Outsourcing & Insourcing
  • Recruitment Strategies
  • Managing recruitment and talentin a post-recession environment
  • Implementing change management
  • International HR strategy
  • Changing Face of HR Function
  • Engagement & Retention
  • Talent Management

Joins some of the experts like:

  • Citi, Senior Vice PresidentHR
  • Raiffeisen International, Senior Vice President HR
  • KLM, Vice President HR CIO/IS
  • The Hertz Corporation, Vice President - Global Talent Management
  • OMV, Head of human resources & orgainization
  • IBM, HR director Benelux
  • Merck Serono, Regional Director of Human Resources Middle East & Near East
  • Novonordisk, Director for performance
  • Unicredit Group, Head of coporate learning & CEO Unimangement
  • Abbott, Global HR Director
  • Royal Bank of Scotland,Director, group organisational effectiveness
  • GSMA, Director Global People Initiative
  • PepsiCo, Human ResourcesDirector Central Functions Europe
  • Group Danone, HR Director baby Nutrition
  • BT Group, MBE, HR Director
  • Astellas Pharma, Senior Director Human Resources and Facilities
  • British American Tobacco, Global Head of HR Transformation and Organization Effectiveness
  • And many more...

Who should attend?
This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

For further information and registration, please visit:
http://www.nwbg.eu/all-events/master-hr-sumit-2011/

Most Popular Now

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...